Type 2 Diabetes, Diabetes Genetic Score and Risk of Decreased Renal Function and Albuminuria: A Mendelian Randomization Study

EBioMedicine

Volumn 6, Issue , 2016, Pages 162-170

  Xu, Min ^a,b   Bi, Yufang ^a,b   Huang, Ya ^a,b   Xie, Lan ^c   Hao, Mingli ^a,b   Zhao, Zhiyun ^a,b   Xu, Yu ^a,b   Lu, Jieli ^a,b   Chen, Yuhong ^a,b   Sun, Yimin ^c,d   Qi, Lu ^e   Wang, Weiqing ^a,b   Ning, Guang ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Tsinghua University   (China)

^d NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

^e TULANE UNIVERSITY   (United States)

Author keywords

Albuminuria; Causal modeling; Genetic epidemiology; Renal function; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALBUMINURIA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; DIABETES GENETIC SCORE; DISEASE ASSESSMENT; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; IMMUNOASSAY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; CHINA; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES; RISK ASSESSMENT;

ALBUMINURIA; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; RISK ASSESSMENT;

EID: 84965005980     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.02.032     Document Type: Article

References (36)

1. Ahmad O.S., Morris J.A., Mujammami M., et al. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat. Commun. 2015, 6:7060. 10.1038/ncomms8060.
2. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15:539-553.
3. Bi Y., Lu J., Wang W., et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study. J. Diabetes 2014, 6:147-157. 10.1111/1753-0407.12108.
4. de Boer I.H. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014, 37:24-30. 10.2337/dc13-2113.
5. de Boer I.H., Sun W., Cleary P.A., et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N. Engl. J. Med. 2011, 365:2366-2376. 10.1056/NEJMoa1111732.
6. Cersosimo E., Solis-Herrera C., Trautmann M.E., et al. Assessment of pancreatic beta-cell function: review of methods and clinical applications. Curr. Diabetes Rev. 2014, 10:2-42. 10.2174/1573399810666140214093600.
7. Cho Y.S., Chen C.H., Hu C., et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat. Genet. 2012, 44:67-72. 10.1038/ng.1019.
8. Cho Y.S., Lee J.Y., Park K.S., et al. Genetics of type 2 diabetes in East Asian populations. Curr. Diab. Rep. 2012, 12:686-696. 10.1007/s11892-012-0326-z.
9. Davey Smith G., Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 2014, 23:R89-R98. 10.1093/hmg/ddu328.
10. DCCT/EDIC research group Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol. 2014, 2:793-800. 10.1016/S2213-8587(14)70155-X.
11. Didelez V., Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat. Methods Med. Res. 2007, 16:309-330. 10.1177/0962280206077743.
12. Ding E.L., Song Y., Manson J.E., et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 2009, 361:1152-1163. 10.1056/NEJMoa0804381.
13. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch. Intern. Med. 1997, 157:1413-1418. 10.1001/archinte.1997.00440340025002.
14. Fall T., Hägg S., Mägi R., et al. The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med. 2013, 10:e1001474. 10.1371/journal.pmed.1001474.
15. Hagstromer M., Oja P., Sjostrom M. The International Physical Activity Questionnaire (IPAQ). A study of concurrent and construct validity. Public Health Nutr. 2006, 9:755-762.
16. Hughes K., Flynn T., de Zoysa J., et al. Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int. 2014, 85:344-351. 10.1038/ki.2013.353.
17. Inker L.A., Astor B.C., Fox C.H., et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney Dis. 2014, 63:713-735. 10.1053/j.ajkd.2014.01.416.
18. Jansen H., Samani N.J., Schunkert H. Mendelian randomization studies in coronary artery disease. Eur. Heart J. 2014, 35:1917-1924. 10.1093/eurheartj/ehu208.
19. Jensen M.K., Bartz T.M., Djousse L., et al. Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study. Diabetes Care 2013, 36:3121-3127. 10.2337/dc12-2323.
20. Jerums G., Panagiotopoulos S., Premaratne E., et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat. Rev. Nephrol. 2009, 5:397-406. 10.1038/nrneph.2009.91.
21. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39:S1-266.
22. Kato N. Insights into the genetic basis of type 2 diabetes. J. Diabetes Investig. 2013, 4:233-244. 10.1111/jdi.12067.
23. Lawlor D.A., Harbord R.M., Sterne J.A., et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 2008, 27:1133-1163. 10.1002/sim.3034.
24. Levey A.S., Coresh J. Chronic kidney disease. Lancet 2012, 379:165-180. 10.1016/S0140-6736(11)60178-5.
25. Liu S., Song Y. Building genetic scores to predict risk of complex diseases in humans: is it possible?. Diabetes 2010, 59:2729-2731. 10.2337/db10-1081.
26. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J. Am. Soc. Nephrol. 2006, 17:2937-2944. 10.1681/ASN.2006040368.
27. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
28. Ning G. Risk evaluation of cancers in Chinese diabetic individuals. A longitudinal (REACTION) study. J. Diabetes 2012, 4:172-173. Reaction Study Group. 10.1111/j.1753-0407.2012.00182.x.
29. Palmer T.M., Lawlor D.A., Harbord R.M., et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med. Res. 2012, 21:223-242. 10.1177/0962280210394459.
30. Qi L. Mendelian randomization in nutritional epidemiology. Nutr. Rev. 2009, 67:439-450. 10.1111/j.1753-4887.2009.00218.x.
31. Rasmussen-Torvik L.J., Li M., Kao W.H., et al. Association of a fasting glucose genetic risk score with subclinical atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes 2011, 60:331-335. 10.2337/db10-0839.
32. Reutens A.T. Epidemiology of diabetic kidney disease. Med. Clin. North Am. 2013, 97:1-18. 10.1016/j.mcna.2012.10.001.
33. Ross S., Gerstein H.C., Eikelboom J., et al. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. Eur. Heart J. 2015, 36:1454-1562. 10.1093/eurheartj/ehv083.
34. So W.Y., Kong A.P., Ma R.C., et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006, 29:2046-2052. 10.2337/dc06-0248.
35. Viberti G.C., Hill R.D., Jarrett R.J., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430-1432. doi:10.1016/S0140-6736(82)92450-3.
36. Zhang L., Wang F., Wang L., et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012, 379:815-822. 10.1016/S0140-6736(12)60033-6.